NCT02025998View on ClinicalTrials.gov

Development of Ibudilast for Alcohol Use Disorder

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Alcohol Use Disorders
Interventions
DRUG

Ibudilast

Ibudilast is a glial cell modulator that inhibits phosphodiesterases -4 and -10 and macrophage migration inhibitory factor.

OTHER

Matched placebo

A matched placebo (suggar pill) will be administered as a control condition.

Trial Locations (1)

90095

UCLA Addictions Laboratory, Los Angeles

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of California, Los Angeles

OTHER

NCT02025998 - Development of Ibudilast for Alcohol Use Disorder | Biotech Hunter | Biotech Hunter